Market Overview:
The global opthalmology drugs and devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye diseases, rising geriatric population, and technological advancements in ophthalmic devices. Based on type, the global opthalmology drugs and devices market is segmented into drugs and devices. The drug segment is further sub-segmented into anti-infectives, glaucoma medications, steroids & other anti-inflammatory agents, dry eye treatments, mydriatics & cycloplegics and others. The device segment is further sub-segmented into diagnostic equipment (ophthalmoscopes/fundus cameras), surgical equipment (lasers/scissors), contact lenses & solutions and others. Based on application, the global opthalmology drugs and devices market is divided into hospitals, clinicsand others segments.
Product Definition:
Opthalmology Drugs and Devices is the branch of medicine that deals with the diagnosis and treatment of disorders of the eye. It is important because it can help to improve vision and prevent blindness.
Device:
The global device, it's usage and growth factor in ophthalmology drugs and devices market size was valued at USD 5.5 billion in 2015. The increasing prevalence of age-associated ophthalmic disorders such as cataract, glaucoma, diabetic retinopathy & macular degeneration is expected to drive the demand for these products over the forecast period.
Drug:
The global drug and it's usage in ophthalmology market size was valued at USD 6.1 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of eye diseases such as glaucoma, cataract, macular degeneration, diabetic retinopathy and others are expected to drive the growth during the forecast period from 2016 to 2020.
Application Insights:
Based on application, the global market is segmented into hospital-based practice, clinic-based practice, and others. Hospital-based practices dominated the overall market in terms of revenue in 2017 owing to factors such as increasing prevalence of eye diseases and growing geriatric population with ocular disorders. The hospital based clinics provide round the clock access to advanced medical care for patients who cannot travel or are too uncomfortable traveling for long distances from their homes.
The other application segment includes retail drug stores and online pharmacies that offer drugs directly to patients through internet without involving a doctor or pharmacist in between.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as favorable government initiatives, high prevalence of ophthalmic disorders, and availability of highly skilled physicians. Moreover, increasing R&D activities by major companies is expected to fuel growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income coupled with improving healthcare infrastructure in emerging countries like China & India.
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The global prevalence of blindness is estimated to be around 7.5 million, while that of low vision is estimated at 217 million. The number of people with visual impairment is expected to double by 2020 and reach more than 550 million. This increasing prevalence is expected to drive the demand for ophthalmology drugs and devices over the forecast period.
- Technological advancements in ophthalmic devices: Ophthalmic device manufacturers are constantly investing in R&D to develop innovative products that can improve the accuracy and efficiency of treatments. For instance, In October 2017, Alcon announced the launch of its Centurion Vision System – a new platform designed to help surgeons achieve better outcomes during cataract surgery procedures. Such technological advancements are expected to boost the growth prospects of the ophthalmology drugs and devices market over the forecast period.
- owing largelyto improvementsin healthcare infrastructureand living standards acrossthe world .This rising geriatric populationisexpectedtodrivethe demandforoph
Scope Of The Report
Report Attributes
Report Details
Report Title
Opthalmology Drugs and Devices Market Research Report
By Type
Device, Drug
By Application
Hosptial, Clinic, Others
By Companies
Merck (US), Pfizer (US), Roche Holdings (Switzerland), Santen Pharmaceutical(Japan), Alcon (Switzerland), Bausch & Lomb (US), Carl Zeiss Meditec (Germany), Essilor International S.A. (France), Johnson & Johnson (US), Nidek(Japan), Topcon Corporation (Japan)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
189
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Opthalmology Drugs and Devices Market Report Segments:
The global Opthalmology Drugs and Devices market is segmented on the basis of:
Types
Device, Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hosptial, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck (US)
- Pfizer (US)
- Roche Holdings (Switzerland)
- Santen Pharmaceutical(Japan)
- Alcon (Switzerland)
- Bausch & Lomb (US)
- Carl Zeiss Meditec (Germany)
- Essilor International S.A. (France)
- Johnson & Johnson (US)
- Nidek(Japan)
- Topcon Corporation (Japan)
Highlights of The Opthalmology Drugs and Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Device
- Drug
- By Application:
- Hosptial
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Opthalmology Drugs and Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Opthalmology drugs and devices are medications or devices used to treat diseases or conditions that affect the eyes, such as glaucoma, macular degeneration, and cataracts.
Some of the major companies in the opthalmology drugs and devices market are Merck (US), Pfizer (US), Roche Holdings (Switzerland), Santen Pharmaceutical(Japan), Alcon (Switzerland), Bausch & Lomb (US), Carl Zeiss Meditec (Germany), Essilor International S.A. (France), Johnson & Johnson (US), Nidek(Japan), Topcon Corporation (Japan).
The opthalmology drugs and devices market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Opthalmology Drugs and Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Opthalmology Drugs and Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Opthalmology Drugs and Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Opthalmology Drugs and Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Opthalmology Drugs and Devices Market Size & Forecast, 2020-2028
4.5.1 Opthalmology Drugs and Devices Market Size and Y-o-Y Growth
4.5.2 Opthalmology Drugs and Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Device
5.2.2 Drug
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hosptial
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Opthalmology Drugs and Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Opthalmology Drugs and Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Device
9.6.2 Drug
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hosptial
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Device
10.6.2 Drug
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hosptial
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Device
11.6.2 Drug
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hosptial
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Device
12.6.2 Drug
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hosptial
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Device
13.6.2 Drug
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hosptial
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Opthalmology Drugs and Devices Market: Competitive Dashboard
14.2 Global Opthalmology Drugs and Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck (US)
14.3.2 Pfizer (US)
14.3.3 Roche Holdings (Switzerland)
14.3.4 Santen Pharmaceutical(Japan)
14.3.5 Alcon (Switzerland)
14.3.6 Bausch & Lomb (US)
14.3.7 Carl Zeiss Meditec (Germany)
14.3.8 Essilor International S.A. (France)
14.3.9 Johnson & Johnson (US)
14.3.10 Nidek(Japan)
14.3.11 Topcon Corporation (Japan)
